Neogen Chemicals マネジメント
マネジメント 基準チェック /44
Neogen Chemicalsの CEO はHarin Kananiで、 Oct2025年に任命され、 の在任期間は 1 年未満です。 の年間総報酬は₹ 13.75Mで、 99.6%給与と0.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の17.02%を直接所有しており、その価値は₹ 9.47B 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と8.5年です。
主要情報
Harin Kanani
最高経営責任者
₹13.8m
報酬総額
| CEO給与比率 | 99.64% |
| CEO在任期間 | less than a year |
| CEOの所有権 | 17.0% |
| 経営陣の平均在職期間 | 2.3yrs |
| 取締役会の平均在任期間 | 8.5yrs |
経営陣の近況
Recent updates
分析記事 • Jul 29
Neogen Chemicals Limited Just Beat EPS By 69%: Here's What Analysts Think Will Happen Next
A week ago, Neogen Chemicals Limited ( NSE:NEOGEN ) came out with a strong set of quarterly numbers that could...
ナラティブ更新 • Jul 28
NEOGEN: Rich P/E And Higher Margin Outlook Will Shape Balanced Returns
Analysts have raised the price target for Neogen Chemicals from ₹1,924 to ₹2,167, citing updated assumptions on revenue growth, profit margin, and future P/E that feed into their valuation models. What’s in the News for Neogen Chemicals A board meeting is scheduled for May 16, 2026 to consider audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, and to consider a possible final dividend recommendation on equity shares, subject to shareholder approval at the 37th AGM.ナラティブ更新 • Jul 14
NEOGEN: Rich P/E And Lower Margin Outlook Will Pressure Future Returns
Analysts have revised their price target for Neogen Chemicals from ₹1,756.25 to ₹1,924.00, citing updated assumptions around discount rate, revenue growth, profit margin and future P/E that collectively change their valuation framework. What’s in the News for Neogen Chemicals A board meeting is scheduled on April 18, 2026 to consider the allotment of 1,000,000 equity shares of face value ₹10 each at ₹1,610 per share, including a premium of ₹1,600 per share, aggregating to ₹161,00,00,000 on a preferential basis to a specified allottee.
ナラティブ更新 • Jun 16
NEOGEN: Preferential Share Issue Will Keep Future P E Excessively Elevated
Analysts have kept their fair value estimate for Neogen Chemicals steady at ₹1,455, citing relatively unchanged assumptions around revenue growth, profit margins and future P/E multiples, along with a slightly lower discount rate that fine tunes but does not materially shift their overall price target view. What’s in the News for Neogen Chemicals A board meeting is scheduled on May 16, 2026 to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend recommendation for approval at the 37th AGM.ナラティブ更新 • Jun 02
NEOGEN: Preferential Equity Issue Will Sustain Pressure On Elevated Future P E
Analysts have raised their price target on Neogen Chemicals from ₹1,335 to ₹1,455, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 16, 2026 to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider recommending a final dividend on equity shares, subject to shareholder approval at the 37th AGM.分析記事 • May 24
Neogen Chemicals' (NSE:NEOGEN) Problems Go Beyond Weak Profit
The market wasn't impressed with the soft earnings from Neogen Chemicals Limited ( NSE:NEOGEN ) recently. We did some...
ナラティブ更新 • May 11
NEOGEN: Preferential Equity Funding Will Support Long Term Upside Potential
Analysts have trimmed their price target for Neogen Chemicals from ₹2,630 to about ₹2,311 as they factor in more moderate revenue growth assumptions, a slightly higher profit margin outlook, and a lower future P/E multiple in their models. What's in the News Board meeting scheduled for April 18, 2026, to consider allotment of 1,000,000 equity shares with face value of ₹10 at an issue price of ₹1,610 per share on a preferential basis, aggregating up to ₹1,610,000,000.ナラティブ更新 • Apr 23
NEOGEN: Equity Fundraising Plans Will Pressure Elevated Future P E Multiple
Analysts have kept their price target for Neogen Chemicals steady at ₹1,335, citing only small refinements to their discount rate, revenue growth outlook and profit margin assumptions, along with a slightly lower future P/E multiple, rather than any major shift in the investment case. What's in the News On February 11, 2026, the board met to review unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025, and to evaluate various options for raising funds through equity and other securities in one or more tranches (company filing).ナラティブ更新 • Apr 09
NEOGEN: Future PE Reset Will Test Sustainability Of Recent Cost Improvements
Narrative Update Analysts have held the fair value estimate for Neogen Chemicals steady at ₹1,335.00 while updating assumptions on growth, margins and future P/E. This reflects recent research that cites stronger revenue and EBITDA performance, cost actions taking hold and higher external price targets in the range of roughly ₹540 to ₹1,000 equivalent.ナラティブ更新 • Mar 25
NEOGEN: Raised Guidance And Cost Actions Will Support Higher Future Earnings Quality
Narrative Update Overview The revised analyst price target for Neogen Chemicals edges slightly lower to ₹1,756.25 from ₹1,769.57. This reflects updated assumptions around the discount rate, revenue growth, profit margin, and future P/E, while staying broadly aligned with recent Street research that has cited better revenue and EBITDA prints, higher guidance, and early benefits from cost actions.ナラティブ更新 • Mar 10
NEOGEN: Future P E Compression Will Challenge Optimism Around Cost Driven Margin Gains
Our updated fair value estimate for Neogen Chemicals shifts to ₹1,335 from ₹1,670 as analysts factor in slightly adjusted growth assumptions, a modestly lower discount rate, firmer profit margins and a reduced future P/E multiple, broadly in line with recent Street research that links higher targets in other names to improving revenue quality, cost actions and guidance. Analyst Commentary Street research around Neogen Chemicals points to a more measured setup, even as some peers in the sector see higher optimism baked into targets.ナラティブ更新 • Feb 24
NEOGEN: Raised Guidance And Cost Actions Will Support Richer Future Earnings Multiple
Analysts have trimmed their fair value estimate for Neogen Chemicals from ₹1,847 to about ₹1,770, as slightly softer revenue growth and margin inputs are being offset by a higher assumed future P/E multiple and recent Street target hikes following better than expected earnings and guidance. Analyst Commentary Recent Street research around Neogen Chemicals reflects a mix of optimism about execution and some caution on how durable the current momentum might be for earnings and valuation.ナラティブ更新 • Feb 10
NEOGEN: Raised Guidance And Cost Actions Will Support Further Upside
Narrative Update: Neogen Chemicals Analysts have lifted their price target on Neogen Chemicals to a range of about $10 to $12, up from $6.50 to $8. This change is attributed to the company’s recent revenue and EBITDA beat, raised guidance, and early benefits from portfolio execution and cost actions.ナラティブ更新 • Jan 26
NEOGEN: Raised Guidance And Upcoming Board Results Will Support Upside
Narrative Update The analyst price target for Neogen Chemicals has been adjusted from approximately ₹1,812 to ₹1,847 as analysts factor in recent research that points to steady fair value assumptions, a slightly higher discount rate, unchanged growth and margin inputs, and a modestly higher future P/E multiple in light of recent earnings commentary and guidance updates on Neogen. Analyst Commentary Recent Street research on Neogen Chemicals highlights a mix of optimism around execution and guidance, paired with some restraint on how far the valuation should stretch after the latest earnings release.ナラティブ更新 • Jan 09
NEOGEN: Steady Fair Value And Upcoming Results Will Support Upside
Analysts have kept their fair value estimate for Neogen Chemicals steady at ₹1,812.29 per share, with only marginal adjustments to the discount rate, revenue growth, profit margin and future P/E inputs that are too small to materially change the target at this time. What's in the News Board meeting scheduled for November 8, 2025, at 14:30 Indian Standard Time to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).ナラティブ更新 • Dec 26
NEOGEN: Market Perform Initiation Will Support Upside From Resilient Margins
Analysts have modestly revised their price target on Neogen Chemicals upward to $10, reflecting slightly higher long term growth expectations and largely stable margin and valuation assumptions. Analyst Commentary The latest initiation at a Market Perform rating with a $10 price target highlights a balanced view on Neogen Chemicals, with analysts seeing the current valuation as broadly aligned with its near to medium term growth prospects.ナラティブ更新 • Dec 11
NEOGEN: Market Perform Initiation Will Support Steady Future Return Potential
Analysts have nudged their price target for Neogen Chemicals slightly higher, reflecting a modest improvement in fair value to roughly ₹1,812 per share. This is supported by expectations of sustained high revenue growth and stable valuation multiples, despite only minor adjustments to discount rate and profit margin assumptions.分析記事 • Dec 04
Why We're Not Concerned Yet About Neogen Chemicals Limited's (NSE:NEOGEN) 26% Share Price Plunge
The Neogen Chemicals Limited ( NSE:NEOGEN ) share price has fared very poorly over the last month, falling by a...ナラティブ更新 • Nov 27
NEOGEN: Broader Customer Base And Joint Venture Will Support Steady Future Returns
Analysts have maintained Neogen Chemicals' price target at $1,806.57, citing stable growth expectations and aligning their assessment with the recent initiation of a Market Perform rating by the Street. Analyst Commentary Bullish Takeaways Bullish analysts note Neogen Chemicals' consistent revenue growth, which supports the current valuation and underpins the stable price target.分析記事 • Nov 16
We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
Neogen Chemicals Limited's ( NSE:NEOGEN ) earnings announcement last week contained some soft numbers, disappointing...分析記事 • Nov 14
Analysts Are More Bearish On Neogen Chemicals Limited (NSE:NEOGEN) Than They Used To Be
One thing we could say about the analysts on Neogen Chemicals Limited ( NSE:NEOGEN ) - they aren't optimistic, having...ナラティブ更新 • Nov 12
NEOGEN: Product Diversification Will Drive Long-Term Returns After New Joint Venture
Analysts have revised Neogen Chemicals' fair value target downward from ₹2,062.83 to ₹1,806.57. This adjustment is due to a slightly higher discount rate and moderated revenue growth expectations, as reflected in recent research updates.分析記事 • Nov 11
These 4 Measures Indicate That Neogen Chemicals (NSE:NEOGEN) Is Using Debt Extensively
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...ナラティブ更新 • Aug 06
Expanding Lithium Battery Materials Will Secure Global Reach
Despite an upward revision in revenue growth forecasts, Neogen Chemicals’ consensus price target has been lowered to ₹2,062, primarily due to a substantial decline in its future P/E multiple. What's in the News Annual dividend decreased to INR 1 per share for FY 2024-25.
新しいナラティブ • Mar 15
Merger With BuLi Chemicals Will Strengthen Market Position In Pharma And Agrochemicals
The merger and strategic product expansions aim to strengthen Neogen's market position and boost future export and domestic revenue growth.分析記事 • Feb 21
Neogen Chemicals Limited's (NSE:NEOGEN) P/S Is On The Mark
When you see that almost half of the companies in the Chemicals industry in India have price-to-sales ratios (or "P/S...分析記事 • Feb 06
Neogen Chemicals Limited Just Missed Earnings - But Analysts Have Updated Their Models
It's been a pretty great week for Neogen Chemicals Limited ( NSE:NEOGEN ) shareholders, with its shares surging 16% to...分析記事 • Dec 26
Here's Why Neogen Chemicals (NSE:NEOGEN) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Dec 10
The Returns On Capital At Neogen Chemicals (NSE:NEOGEN) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...分析記事 • Nov 20
Why Neogen Chemicals' (NSE:NEOGEN) Shaky Earnings Are Just The Beginning Of Its Problems
A lackluster earnings announcement from Neogen Chemicals Limited ( NSE:NEOGEN ) last week didn't sink the stock price...分析記事 • Nov 16
Earnings Miss: Neogen Chemicals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
Last week, you might have seen that Neogen Chemicals Limited ( NSE:NEOGEN ) released its second-quarter result to the...分析記事 • Sep 20
Investors Appear Satisfied With Neogen Chemicals Limited's (NSE:NEOGEN) Prospects As Shares Rocket 36%
The Neogen Chemicals Limited ( NSE:NEOGEN ) share price has done very well over the last month, posting an excellent...分析記事 • May 08
We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
Neogen Chemicals Limited's ( NSE:NEOGEN ) recent weak earnings report didn't cause a big stock movement. We think that...分析記事 • May 05
Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts
As you might know, Neogen Chemicals Limited ( NSE:NEOGEN ) last week released its latest full-year, and things did not...分析記事 • Apr 26
After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar
Neogen Chemicals Limited ( NSE:NEOGEN ) shares have had a really impressive month, gaining 27% after a shaky period...CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | ₹356m |
| Mar 31 2026 | ₹14m | ₹14m | ₹288m |
| Dec 31 2025 | n/a | n/a | ₹197m |
| Sep 30 2025 | n/a | n/a | ₹261m |
| Jun 30 2025 | n/a | n/a | ₹336m |
| Mar 31 2025 | ₹15m | ₹14m | ₹348m |
| Dec 31 2024 | n/a | n/a | ₹494m |
| Sep 30 2024 | n/a | n/a | ₹404m |
| Jun 30 2024 | n/a | n/a | ₹374m |
| Mar 31 2024 | ₹20m | ₹13m | ₹357m |
| Dec 31 2023 | n/a | n/a | ₹330m |
| Sep 30 2023 | n/a | n/a | ₹467m |
| Jun 30 2023 | n/a | n/a | ₹486m |
| Mar 31 2023 | ₹8m | ₹8m | ₹500m |
| Dec 31 2022 | n/a | n/a | ₹513m |
| Sep 30 2022 | n/a | n/a | ₹471m |
| Jun 30 2022 | n/a | n/a | ₹484m |
| Mar 31 2022 | ₹6m | ₹6m | ₹446m |
| Dec 31 2021 | n/a | n/a | ₹383m |
| Sep 30 2021 | n/a | n/a | ₹364m |
| Jun 30 2021 | n/a | n/a | ₹326m |
| Mar 31 2021 | ₹5m | ₹5m | ₹313m |
| Dec 31 2020 | n/a | n/a | ₹293m |
| Sep 30 2020 | n/a | n/a | ₹290m |
| Jun 30 2020 | n/a | n/a | ₹293m |
| Mar 31 2020 | ₹5m | ₹5m | ₹287m |
報酬と市場: Harinの 総報酬 ($USD 144.47K ) は、 Indian市場 ($USD 279.27K ) の同様の規模の企業の平均を下回っています。
報酬と収益: Harinの報酬は、過去 1 年間の会社の業績と一致しています。
CEO
Harin Kanani (50 yo)
less than a year
在職期間
₹13,750,000
報酬
Dr. Harin Haridas Kanani, Ph D serves as the Managing Director of Neogen Chemicals Limited since July 22, 2017 and serves as its Executive Director since July 15, 2013. Dr. Kanani served as Joint Managing...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Executive Director | less than a year | ₹13.75m | 17.02% ₹ 9.5b | |
| Director of Operations & Whole Time Director | no data | ₹12.35m | 0.00029% ₹ 161.3k | |
| Chief Financial Officer | 1.8yrs | データなし | データなし | |
| Company Secretary & Compliance Officer | 6.8yrs | ₹690.56k | データなし | |
| Senior General Manager of Marketing | no data | データなし | データなし | |
| Senior Vice President of Human Resource | no data | データなし | データなし | |
| Senior Vice President of Business Development | 2.8yrs | データなし | データなし |
2.3yrs
平均在職期間
50yo
平均年齢
経験豊富な経営陣: NEOGENの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Executive Director | 13.1yrs | ₹13.75m | 17.02% ₹ 9.5b | |
| Director of Operations & Whole Time Director | 11.1yrs | ₹12.35m | 0.00029% ₹ 161.3k | |
| Non-Executive Non-Independent Chairman | 9.3yrs | データなし | 0.82% ₹ 457.1m | |
| Chairman Emeritus | 37.4yrs | ₹8.90m | 6.41% ₹ 3.6b | |
| Independent Non-Executive Director | 7.8yrs | ₹1.10m | データなし | |
| Independent Non-Executive Woman Director | 7.8yrs | ₹1.10m | データなし | |
| Independent Director | 2yrs | ₹2.40m | 0.0011% ₹ 611.9k | |
| Independent Director | 1.8yrs | ₹2.60m | データなし |
8.5yrs
平均在職期間
67yo
平均年齢
経験豊富なボード: NEOGENの 取締役会 は 経験豊富 であると考えられます ( 8.5年の平均在任期間)。
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/08/07 14:24 |
| 終値 | 2026/08/07 00:00 |
| 収益 | 2026/06/30 |
| 年間収益 | 2026/03/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Neogen Chemicals Limited 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。19
| アナリスト | 機関 |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Asian Markets Securities Private Limited |
| Arun Prasath | Avendus Spark |